close

Fundraisings and IPOs

1 2 3 4 5 67
Number of results: 1334
Date Company Amount Funding type Investors Therapeutic area Type of Information
2017-07-25 VenatoRx Pharmaceuticals (USA - PA) up to $ 9.4 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-19 Ose Immunotherapeutics (France) €9.2 million grant Bpifrance (France) Cancer - Oncology Grant
2017-07-19 Akcea Therapeutics (USA - MA) $193.8 million IPO - private placement Cardiovascular diseases - Metabolic diseases - Rare diseases IPO
2017-07-18 Eurofins Scientific (Luxembourg) € 65 million fundraising Technology - Services Fundraising
2017-07-18 Neurovive Pharmaceutical (Sweden) SEK 9 million (€ 0.94 million) private placement Esousa Holdings (USA - NY) Rare diseases - Genetic diseases - Liver diseases - Hepatic diseases Private placement
2017-07-17 Paion (Germany) € 8 million private placement two undisclosed U.S. institutional investors CNS diseases Private placement
2017-07-07 Biophytis (France) € 18,7 million capital increase - private placement Bracknor Investment Group (Dubai) Ageing diseases - Muscle disorders - Ophtalmological diseases Capital increase
2017-07-06 Evotec (Germany) grant Hamburgische Investitions- und Förderbank (IFB Hamburg) (Germany) Cancer - Oncology Grant
2017-07-06 Zealand Pharma (Denmark) capital increase Capital increase
2017-07-05 Anaeropharma Science (Japan) $13.2 million financing round Novartis (Switzerland) Shinsei Corporate Investment (Japan) Seventure Partners (France) Innovation Network Corporation of Japan (Japan) Mitsubishi UFJ Capital (Japan) Cancer - Oncology - Cardiovascular diseases Financing round
2017-07-03 Sensorion (France) up to €25 million financing round Yorkville Advisors Global (USA) Otorhinolaryngology Financing round
2017-06-29 Melinta Therapeutics (USA - CT) $ 90 million loan Oberland Capital (USA - NY) Infectious diseases Loan
2017-06-27 Daytwo (Israel) $12 million series A financing round Seventure Partners (France), J&J (USA - NJ) historical investors Series A financing round
2017-06-27 LogicBio Therapeutics (USA - MA) $ 50 million series B financing round Arix Bioscience (UK) OrbiMed (USA - NY) Edmond de Rothschild Investment Partners (France) Pontifax (Israel) SBI Japan-Israel Innovation Fundalso (Israel - Japan) Rare diseases - Genetic diseases - Infectious diseases Series B financing round
2017-06-23 Gensight Biologics (France) €22.5 million capital increase Rare diseases - Genetic diseases - Ophtalmological diseases Capital increase
2017-06-21 Clovis Oncology (USA - CO) $300 million private placement Cancer - Oncology Private placement
2017-06-20 iOnctura (Switzerland) financing round Merck Ventures (Germany) Cancer - Oncology Financing round
2017-06-20 Loxo Oncology (USA - CA) $260.8 million private placement Cancer - Oncology Private placement
2017-06-20 Onxeo (France) €15 Million private placement Cancer - Oncology - Rare diseases Private placement
2017-06-14 Medixci (UK - Switzerland) $300 million financing round Novartis (Switzerland) Verily, an Alphabet company (USA - CA) European Investment Fund (EIF) (EU) institutional LPs Financing round